Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine

2017 ◽  
Vol 31 (6) ◽  
pp. e304-e306 ◽  
Author(s):  
S. Ljubojevic Hadzavdic ◽  
D. Stulhofer Buzina ◽  
I. Murtezani ◽  
M. Skerlev
Keyword(s):  
Colon Carcinoma ◽  
Metastatic Colon Carcinoma

scholarly journals A Case of Metastatic Colon Carcinoma Originating from the Uterus.

2000 ◽  
Vol 33 (5) ◽  
pp. 648-652 ◽  
Author(s):  
Hirokazu Taniguchi ◽  
Mitsugu Sekimoto ◽  
Naohiro Tomita ◽  
Masayuki Ohue ◽  
Yasuhiro Tamaki ◽  
...  
Keyword(s):  
Colon Carcinoma ◽  
Metastatic Colon Carcinoma

Discrepancies in carcinoembryonic antigen measurements: survey and control values vs values for patients.

1987 ◽  
Vol 33 (4) ◽  
pp. 563-566 ◽  
Author(s):  
G G Klee ◽  
L A Dodge ◽  
G Reynoso
Keyword(s):  
Tissue Culture ◽  
Carcinoembryonic Antigen ◽  
Enzyme Immunoassay ◽  
Colon Carcinoma ◽  
Proficiency Testing ◽  
Analytical Methods ◽  
Test Results ◽  
And Control ◽  
The Relationship ◽  
Metastatic Colon Carcinoma

Abstract We analyzed the carcinoembryonic antigen (CEA) test results reported in the College of American Pathologists' (CAP) surveys to determine the relationship between the source of CEA used to manufacture the survey specimens and the discrepancies among analytical methods. With the 1983 survey specimens, which were prepared from metastatic colon carcinoma, laboratories using Roche RIA with Clinetics columns reported results that were only one-half the values reported by laboratories using the Abbott polyclonal enzyme immunoassay. With the 1984 specimens, prepared from a different metastatic colon carcinoma, and the 1985 specimens, prepared from a tissue-culture source of CEA, the Roche results were about one-sixth as large as the Abbott results. These differences are larger than the reported assay differences for patients' specimens. In addition, twofold proportional differences were found when survey and control specimens were tested with different lots of Abbott polyclonal reagent, whereas only random differences were found with 102 patients' specimens. Evidently, assay systems perform differently with proficiency-testing and control specimens than with patients' specimens.

Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments.

Radiology ◽  
1983 ◽  
Vol 149 (2) ◽  
pp. 549-555 ◽  
Author(s):  
P J Moldofsky ◽  
J Powe ◽  
C B Mulhern ◽  
N Hammond ◽  
H F Sears ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Colon Carcinoma ◽  
Antibody Fragments ◽  
Metastatic Colon Carcinoma

A Rare Case of a Skeletal Muscle Mass as an Initial Presentation of Metastatic Colon Carcinoma

2014 ◽  
Vol 109 ◽  
pp. S412
Author(s):  
Kosana Simeunovic ◽  
Deepak Sharma ◽  
Varun Jain ◽  
Julijana Botic ◽  
Vimala Ramasamy ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Muscle Mass ◽  
Colon Carcinoma ◽  
Rare Case ◽  
Skeletal Muscle Mass ◽  
Initial Presentation ◽  
Metastatic Colon Carcinoma

scholarly journals Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth

2003 ◽  
Vol 107 (5) ◽  
pp. 739-746 ◽  
Author(s):  
Kelli M. Bullard ◽  
Hyeong-Rok Kim ◽  
Marie A. Wheeler ◽  
Christopher M. Wilson ◽  
Cheryl L. Neudauer ◽  
...  
Keyword(s):  
Colon Carcinoma ◽  
Carcinoma Cells ◽  
Cellular Growth ◽  
Hyaluronan Synthase ◽  
Colon Carcinoma Cells ◽  
Metastatic Colon Carcinoma

Metastatic Colon Carcinoma to the Prostate Gland

2013 ◽  
Vol 37 (3) ◽  
pp. 463-465 ◽  
Author(s):  
Arnold Kang ◽  
Jean Hwa Lee ◽  
Edward Lin ◽  
Maria Westerhoff
Keyword(s):  
Colon Carcinoma ◽  
Prostate Gland ◽  
Metastatic Colon Carcinoma
Sign in / Sign up

Export Citation Format

Share Document